Back

Antiarrhythmic medication for atrial fibrillation (AIM-AF) study: a physician survey of antiarrhythmic drug (AAD) treatment practices and guideline adherence in Europe

27 August 2021 (08:00 - 20:00)
Organised by:
Congress Presentation Part of: Atrial fibrillation e-posters Rhythm Control, Antiarrhythmic Drugs ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Professor Madelene Carina Blomstrom-Lundqvist

Orebro University Hospital, Orebro (Sweden)

160 More presentations in this session

Presentation thumbnail
The impact of abnormal conduction zone on outcomes after catheter ablation for atrial fibrillation
Associate Professor T. Mine (Nishinomiya, JP)
Abstract Slides
Presentation thumbnail
Thromboembolic risk of movable type left atrial appendage thrombi in patients with atrial fibrillation under widespread use of anticoagulants
Doctor M. Sugitani (Nishinomiya, JP)
Abstract Slides
Presentation thumbnail
Rate and rhythm control treatment in the elderly and very elderly patients with atrial fibrillation: an observational cohort study of 1,497 patients
Mr T. Klamer (Amsterdam, NL)
Abstract Slides
Presentation thumbnail
One year outcome and analysis of peri-device leak of left atrial appendage occlusion devices
Doctor M. Mansour (Beirut, LB)
Abstract Slides
Presentation thumbnail
Risk prediction of atrial fibrillation and its complications in the community using high-sensitivity cardiac Troponin I: Results from the BiomarCaRE Consortium
Doctor C. Boerschel (Hamburg, DE)
Abstract Slides

Access the full session

Session thumbnail
Atrial fibrillation e-posters

The Event

Event poster

ESC Congress 2021 - The Digital Experience

27 August 2021 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Which patients with atrial fibrillation undergo an ablation procedure today in Europe? A report from the ESC-EHRA-EURObservational Research Programme
31 August 2019
thumbnail
Congress Presentation
Treating the unknown: the use of anti-arrhtyhmic drugs in idiopathic ventricular fibrillation
14 April 2026
thumbnail
Congress Presentation
Amiodarone in contemporary clinical practice: the rates of and reasons for permanent drug discontinuation
3 September 2019
thumbnail
Congress Presentation
Antithrombotic prescription in secondary cardiovascular prevention: are we following the guidelines?
4 April 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources